LBX(SH:603883) Xin Lang Zheng Quan·2025-09-18 05:20Core Viewpoint - The stock price of Lao Bai Xing has shown fluctuations, with a year-to-date increase of 7.24% but a significant decline over the past 60 days, indicating potential volatility in the market [2]. Company Overview - Lao Bai Xing Pharmacy Chain Co., Ltd. is located in Changsha, Hunan Province, established on December 1, 2005, and listed on April 23, 2015. The company primarily engages in the retail chain business of pharmaceuticals and health-related products [2]. - The revenue composition of the company includes 80.95% from Western and Chinese medicines, 12.11% from non-pharmaceutical products, and 6.94% from traditional Chinese medicine [2]. - As of June 30, 2025, the number of shareholders is 43,600, a decrease of 9.16% from the previous period, with an average of 17,396 circulating shares per shareholder, an increase of 10.08% [2]. Financial Performance - For the first half of 2025, Lao Bai Xing reported a revenue of 10.774 billion yuan, a year-on-year decrease of 1.51%, and a net profit attributable to shareholders of 398 million yuan, down 20.86% year-on-year [2]. - Since its A-share listing, the company has distributed a total of 2.069 billion yuan in dividends, with 991 million yuan distributed over the past three years [3]. Shareholding Structure - As of June 30, 2025, the top ten circulating shareholders include Hong Kong Central Clearing Limited as the third-largest shareholder with 15.0804 million shares, a decrease of 3.0999 million shares from the previous period. New entrants include Southern CSI 1000 ETF and Guotai Medical Health Stock A [3].